How It Works
Klinrisk is building multiple prognostic tests for cardiovascular, renal, and metabolic conditions to address the needs of patients, providers, and health systems
For these related chronic conditions, routine lab data can provide actionable risk stratification and identify high risk patients earlier in their journey before it’s too late
Klinrisk integrates with existing clinical workflows to empower providers at the point of care
What does a Klinrisk report tell me?
Klinrisk products are built for all patients with or at risk of kidney, heart, or metabolic disease. The Klinrisk report can help identify patients at elevated risk for disease progression so healthcare providers can prevent decline.
Klinrisk reports equip providers with guideline-directed care plans based on personalized patient risk, so providers and patients can work together to reduce the chances of developing late stage disease.
No special testing required
Other tests require doctors to measure special values or send patient samples to proprietary labs outside their service area, causing confusion, delays, and implementation issues.
Regular blood and urine tests ordered by doctors produce significant amounts of information that can be used to diagnose and manage chronic disease. Adding Klinrisk analyses to standard lab test results enables healthcare providers to manage complex chronic disease at the point of care without the need for new processes or service providers.
Our Products
-
Regulated Diagnostics
Klinrisk is bringing AI to labs and clinics in partnership with global diagnostic manufacturers. Unlike most AI tools, our products are rigorously documented, validated, and monitored under global requirements for medical devices.
-
Drug Development
Klinrisk helps Biopharma companies optimize trials and drive standard of care therapy in market. How we help:
Phase III decisions: providing intelligent insights into Phase II data to help sponsors decide on targets and design
Monitor and predict trial outcomes, including event rates
Detect risk-treatment heterogeneity
High risk prognostic enrichment and synthetic control arms
Drive guideline-directed therapy in market with Klinrisk clinical decision support
-
Population Health
Klinrisk finds high risk individuals in the sea of cardio-kidney-metabolic syndrome, then provides a guideline-directed care plan for each individual, enabling multi-specialty care management.